VAISHALI PHARMA
Back to Balance Sheet
|
VAISHALI PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.18 Cr | ₹-0.18 Cr | ₹-0.14 Cr | ₹-0.16 Cr | ₹-0.15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VAISHALI PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.18 Cr |
| Mar2024 | ₹-0.18 Cr |
| Mar2023 | ₹-0.14 Cr |
| Mar2022 | ₹-0.16 Cr |
| Mar2021 | ₹-0.15 Cr |
How is Deferred Tax Assets / Liabilities of VAISHALI PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.18 Cr | Negative | |
| Mar2024 | ₹-0.18 Cr | Negative | |
| Mar2023 | ₹-0.14 Cr | Negative | |
| Mar2022 | ₹-0.16 Cr | Negative | |
| Mar2021 | ₹-0.15 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹79.2 Cr | -6.6% | -23.7% | -54.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -6.6% |
-23.7% |
-54.6% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses